10th Apr 2006 07:01
Synexus Clinical Research PLC10 April 2006 Synexus Clinical Research plc ("Synexus" or "the Company") Pre-Close Trading Statement Synexus, the clinical trials services group, today announces the followingpre-close trading update ahead of its preliminary results for the year to 31March 2006. Further to the four months trading results reported in its AIM admissiondocument issued in November 2005, the Company is pleased to report that tradinghas continued to be buoyant and that results for the year to 31 March 2006 aretherefore anticipated to be in line with management expectations. Since its flotation, Synexus has vigorously pursued its stated strategy oforganic growth combined with strategic partnerships and acquisitions to expandits business into emerging economies. To this end, Synexus has established thefirst Site Management Organisation in India through a strategic alliance withthe Indian Clinical Research Institute. Furthermore, in January 2006, theCompany acquired the Polish clinical trials business Skandynawskie CentrumMedyczne Sp. z.o.o. ("SCM"). This acquisition will allow Synexus to exploit thegrowing opportunities for clinical trials and patient recruitment in Central andEastern European markets. The Company continues to pursue a number of other opportunities to replicate itsbusiness in new territories with particular emphasis on those within Central andEastern Europe and has a number of potential targets currently under review. TheCompany is strengthening its management team at the senior operational level,broadening its skills base and providing further capability to support itsgrowth, both in emerging clinical trial markets and in the UK. Enquiries for our services remain strong and the forward order book coversaround 60% of the current market estimate of income for the year ending 31 March2007. Synexus expects to announce its preliminary results for the year to 31 March2006 on 6 June 2006. Press enquiries Synexus Clinical Research plc Tel: +44 (0)1257 230 723Michael Fort, Chief Executive Biddicks - Financial Public Relations Tel: +44 (0)20 7448 1000Zoe Biddick This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synectics